beaker
 

Products

Zurex Pharma, Inc. plans to complete the development and commercialization of at least three novel, proprietary antimicrobial products designed to prevent or minimize Hospital Acquired Infections and targeted for three distinct critical care areas:

  • ZuraPrep™: Presurgical skin preparation for the prevention of surgical site infections (SSI).
  • ZurAsept™: Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.
  • ZuraGard™: Prevention of extra-luminal or “exit site” wound catheter-related bloodstream infections.
PharmAgra

New Ag Products

ZuraLac™ is specifically formulated to sanitize and protect teats from mastitis causing organisms, and protect teat skin tissue from harsh environmental conditions.

Contact

Contact

Zurex Pharma's corporate office is located in the Middleton Industrial Park. Specific comments or questions may be submitted online through our contact page.

ZuraPrep™

Presurgical skin preparation for the prevention of surgical site infections.

Read More

ZurAsept™

Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.

Read More

ZuraGard™

Prevention of extra-luminal or “exit site” wound catheter-related bloodstream infections.

Read More

Publications

Read more about the Zurex product lines from other publications and scientific journals.

Visit Publications Page

Zurex Product Line

Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with healthcare acquired infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).